Operations
Jacqueline de Leeuw, chief nurse innovation officer at Radboud University Medical Centre (Radboudumc), tells how the hospital achieved HIMSS EMRAM Stage 7, allowing its nurses to access a seamless data flow from multiple external sources.
BeMeHealth reveals new strategic investor and expanded offering, Hinge Health announces additional technology for seniors, and Noom extends its enterprise solution.
At HLTH 2023, the venture firm's CEO and the former CEO of Intermountain Health announced the formation of HATCo alongside plans to purchase a health system.
Gill Margolin, CTO of Talkspace, relays how machine learning algorithms have been trained in suicide risk and crisis identification and how the company measures its effectiveness in strengthening the patient/therapist relationship.
Francine de Stoppelaar, Hospital Wide Operational Activation Lead of Cleveland Clinic London, tells how the private hospital built a native digital system through years of preparation, and the challenges and rewards that came with the build.
Members of Mount Sinai Solutions' employer or union customers will receive $110 in Fresh Funds for grocery deliveries after undergoing surgery or giving birth.
Hans Hioyos, field CISO of Prophecy, Americas, discusses how the cybersecurity forum helped him advance his learning of the various layers of security and expand his network as a cybersecurity specialist in the medical field.
Dr. Aalpen Patel, chair of radiology and medical director of AI at Geisinger, explains when to use AI in clinical and administrative care and how Geisinger employs the tech for population health using preventative screening prediction models.
Toni Laracuente, SVP and head of analytics for HIMSS, discusses the Infrastructure Adoption Model (INFRAM), which weighs care-delivery environment functionalities to ensure systems get the highest value from digital health infrastructure.
The biotechnology company told MobiHealthNews it will continue to work within the digital health space through partnerships linked to its 'evolving R&D and commercial priorities.'